Snowball logo
logo
ONCO_logo

Oncopeptides AB

ONCO β€’ ST
SEK 1.589+SEK 0.019Β  (1.21%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
118.38.35535.2231.6571.1283.35
COGS
53.120.006(1.079)2.66312.122.856
Gross Profit
65.178.34936.328.985980.49
Operating Expenses & Income
Operating Income
(1,420.9)(349.4)(253.4)(283.5)(225.9)(206.4)
Total Operating Expenses
1,486.1357.7289.7312.5287.9286.9
R&D Expenses
679.9217.7106.9121.299.8185.08
Selling General & Admin Expenses
175.584.0968.8860.8457.4464.47
Earnings from Continuing Operations
Interest Expense
(0.948)(0.883)(5.785)(12.66)(14.45)(22.73)
Interest Income
0.45511.678.5928.19723.5222.73
Income Tax Expense
8.9460.2710.6640.3981.4151.492
Net Income
Net Income
(1,430.3)(338)(249.1)(284.6)(249.6)(221.1)
Supplemental
EBIT
(1,420.4)(336.8)(242.7)(271.6)(228.9)-
EBITDA
(1,399.1)(319.6)(231.6)(261.8)(219.3)(205.7)
In millions of SEK, except % and values per 1 share